NEW YORK, Oct. 26, 2023 /PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies.
Moore Kuehn is investigating whether the Boards of the below companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process:
- POINT Biopharma Global, Inc. (NASDAQ: PNT)
POINT Biopharma Global has agreed to merge with Eli Lilly. Under the proposed transaction POINT Biopharma shareholders will receive $12.50 in cash per share.
- Vericity, Inc. (NASDAQ: VERY)
Vericity has agreed to merge with iA American Holdings. Under the proposed transaction Vericity shareholders will receive $11.43 in cash per share.
- Mirati Therapeutics, Inc. (NASDAQ: MRTX)
Mirati Therapeutics has agreed to merge with Bristol Myers Squibb. Under the proposed transaction, Mirati Therapeutics shareholders will receive $58.00 in cash and a CVR of up to $12.00 per share.
- Orchard Therapeutics plc (NASDAQ: ORTX)
Orchard Therapeutics has agreed to merge with Kyowa Kirin Co. Under the proposed transaction Orchard Therapeutics shareholders will receive $16.00 in cash and a contingent value right ("CVR") of up to $1.00 per American Depositary Share.
Moore Kuehn encourages shareholders who would like to discuss their rights to contact Justin Kuehn, Esq. by email at jkuehn@moorekuehn.com. The consultation and case are free with no obligation to you. Moore Kuehn pays all case costs and does not charge its investor clients.Shareholders should contact the firm immediately as there may be limited time to enforce your rights.
Moore Kuehn is a 5-star Google client-rated New York City law firm with attorneys representing investors and consumers in litigation involving securities laws, fraud, breaches of fiduciary duties, and other claims. For additional information about Moore Kuehn, please visit http://www.moorekuehn.com/practice/new-york-securities-litigation/.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contacts:
Moore Kuehn, PLLC
Justin Kuehn, Esq.
30 Wall Street, 8th Floor
New York, New York 10005
jkuehn@moorekuehn.com
(212) 709-8245
View original content to download multimedia:https://www.prnewswire.com/news-releases/moore-kuehn-encourages-pnt-very-mrtx-and-ortx-investors-to-contact-law-firm-301969015.html
SOURCE MOORE KUEHN
